跳至主要内容
临床试验/CTRI/2025/03/081943
CTRI/2025/03/081943尚未招募2/3 期

An assessment of effectiveness of Abhijeet Tail Nasya Viddhakarma and Antioxidant Therapy with Antioxidant Therapy only in symptoms of Vataja Timir w.r.t Age Related Macular Degeneration(Dry Type).A Randomized Controlled Clinical Trial.

Dr Siddhi Dichwalkar1 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2025年4月1日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
72
试验地点
1
主要终点
Abhijeet Tail Nasya,Viddhakarma and Antioxidant Therapy is significantly effective than Antioxidant Therapy only in symptoms of Vataja Timir w.r.t Age Related Macular Degeneration (Dry Type).

研究概览

简要总结

this is a randomized controlled clinical trial assessing the effectiveness of abhijeet tail nasya,viddhakarma and antioxidant with antioxidant therapy only given for 21 days in 72 patients. Patients will be observed for 42 days.

the primary outcome is to see the effect of treatment on vataja timir (A.R.M.D) symptoms.

secondary outcome is to see effect on visual acuity, amsler grid, Pelli Robson chart contrast sensitivity chart.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
50.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Patients with distant vision less than or equal to 6/9 with symptoms like Bhramativa Darshana (objects seems to be moving), Aavila Darshana (blur vision),Vyavidha Darshana (metamorphopsia) will be taken.

排除标准

  • 1.retinal diseases except ARMD dry type.
  • 2.systemic diseases which affect macula like uncontrolled DM,hypertension,HIV,HbsAg diseases, psychiatric disorders 3.cataract patients.
  • 4.Patients contraindicated for Nasya and siravedha.
  • 5.patient with skin diseases.

结局指标

主要结局

Abhijeet Tail Nasya,Viddhakarma and Antioxidant Therapy is significantly effective than Antioxidant Therapy only in symptoms of Vataja Timir w.r.t Age Related Macular Degeneration (Dry Type).

时间窗: follow up on 0th,7th,14th,21st,28th,42nd day

次要结局

  • Abhijeet Tail Nasya,Viddhakarma and Antioxidant Therapy is not significantly effective than Antioxidant Therapy only in symptoms of Vataja Timir w.r.t Age Related Macular Degeneration (Dry Type).(follow up on day 0th,7th,14th,21st,28th,42nd day)

研究者

发起方
Dr Siddhi Dichwalkar
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Siddhi Dichwalkar

Maharashtra University health science, Nashik

研究点 (1)

Loading locations...

相似试验